|
Alieva A.M., Reznik E.V., Teplova N.V., Batov M.A., Shnahova L.M., Arakelyan R.A., Baykova I.E., Totolyan G.G., Volynkina V.M., Kislyakov V.A., Nikitin I.G.
Prognostic value of cardiac troponins in case of COVID-19
|
№3 / 2022
|
|
Derevyanchenko M.V., Fedotov V.V., Shaposhnikova M.Yu., Kolodin S.V.
Assessment of the risk of developing cardiovascular diseases on the SCORE-2 and SCORE 2-OP scale in patients with arterial hypertension using software tools
|
№3 / 2022
|
|
Alieva A.M., Teplova N.V., Reznik E.V., Valiev R.K., Rakhaev A.M., Kudaeva M.V., Akhmatov I.Z., Arakelyan R.A., Nikitin I.G.
Biomarkers in cardiology: lipocalin associated with neutrophil gelatinase (NGAL) and cardiovascular diseases
|
№1 / 2022
|
|
Posnenkova O.M., Kaluta T.Yu.
Practical issues of oral iron administration for anemia in patients with cardiovascular diseases
|
№10 / 2021
|
|
Mazurov V.I., Melnikov Е.S., Bashkinov R.A.
Effect of platelets on the course of rheumatoid arthritis and cardiovascular risk
|
№10 / 2021
|
|
Alieva A.M., Baykova I.E., Khadzhieva N.H., Ettinger O.A., Arakelyan R.А., Valiev R.K., Rakhaev A.M., Batov М.А., Elmurzaeva D.А., Malkarova D.S., Nikitin I.G.
Resistin and cardiovascular pathology
|
№9 / 2021
|
|
Shishkova V.N., Kotova M.B., Kapustina L.A., Imamgayazova K.E.
Issues of pathogenesis of cognitive and psychoemotional disorders in patients with cardiovascular and metabolic diseases
|
№8 / 2021
|
|
Avdeeva I.V., Burko N.V., Makarova Kar.N., Makarova Kr.N., Oleynikov V.E.
COVID-19 and cardiovascular diseases: a dangerous tandem
|
№5 / 2021
|
|
Demidova T.Yu., Kishkovich Yu.S.
Prediabetes: what do we know about it today?
|
№8 / 2020
|
|
Demidova T.Yu., Izmailova M.Ya., Lobanova K.G.
Innovative hypoglycemic technologies in the practice of general physician
|
№8 / 2020
|
|
Rukavishnikov G.V., Neznanov N.G., Martynov A.I., Mazo G.E.
Treatment of depression in patients with comorbid somatic diseases
|
№3 / 2020
|
|
Adasheva T.V., Bolieva L.Z., Lee V.V., Malyavin A.G.
Use of beta-blockers in COPD: mythical risk or justified benefit?
|
№5 / 2019
|
Русский
